Skip to main content
Erschienen in: European Journal of Epidemiology 8/2023

31.05.2023 | DIABETES MELLITUS

Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes

verfasst von: Yoosun Cho, Yoosoo Chang, Seungho Ryu, Sarah H. Wild, Christopher D. Byrne

Erschienen in: European Journal of Epidemiology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Whether non-alcoholic fatty liver disease (NAFLD) improves risk prediction for subsequent type 2 diabetes mellitus (T2DM) in women with prior gestational diabetes mellitus (pGDM) is uncertain. We examined the combined effects of NAFLD and pGDM on risk prediction for incident T2DM. This retrospective cohort study included 97,347 Korean parous women without diabetes mellitus at baseline whose mean (SD) age was 39.0 (7.8) years. Cox proportional hazards models were used to estimate hazard ratios (HRs) for incident T2DM according to self-reported pGDM and ultrasound-diagnosed NAFLD at baseline. When combined with conventional diabetes risk factors, the incremental predictive ability of NAFLD and pGDM to identify incident T2DM was assessed. During a median follow-up of 3.9 years, 1,515 cases of incident T2DM occurred. Multivariable-adjusted HRs (95% confidence intervals [CIs]) for incident T2DM comparing pGDM alone, NAFLD alone, and both NAFLD and pGDM to the reference (neither NAFLD nor pGDM) were 2.61 (2.06–3.31), 2.26 (1.96–2.59), and 6.45 (5.19-8.00), respectively (relative excess risk of interaction = 2.58 [95% CI, 1.21–3.95]). These associations were maintained after adjusting for insulin resistance, body mass index, and other potential confounders as time-dependent covariates. The combination of NAFLD and pGDM improved risk prediction for incident T2DM (based on Harrell’s C−index, also known as the concordance index, and net reclassification improvement) compared to conventional diabetes risk factors. In conclusion, NAFLD synergistically increases the risk of subsequent T2DM in women with pGDM. The combination of NAFLD and pGDM improves risk prediction for T2DM.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat American Diabetes Association Professional Practice C. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):17–S38.CrossRef American Diabetes Association Professional Practice C. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):17–S38.CrossRef
2.
Zurück zum Zitat Wang H, Li N, Chivese T, et al. IDF Diabetes Atlas: estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of diabetes in pregnancy Study Group’s Criteria. Diabetes Res Clin Pract. 2022;183:109050.PubMedCrossRef Wang H, Li N, Chivese T, et al. IDF Diabetes Atlas: estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of diabetes in pregnancy Study Group’s Criteria. Diabetes Res Clin Pract. 2022;183:109050.PubMedCrossRef
3.
Zurück zum Zitat Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020;369:m1361.PubMedCrossRefPubMedCentral Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020;369:m1361.PubMedCrossRefPubMedCentral
4.
Zurück zum Zitat Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62(6):905–14.PubMedCrossRef Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62(6):905–14.PubMedCrossRef
5.
Zurück zum Zitat Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.PubMedCrossRef Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84.PubMedCrossRef
6.
Zurück zum Zitat Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol. 2021;6(7):578–88.PubMedCrossRef Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol. 2021;6(7):578–88.PubMedCrossRef
7.
Zurück zum Zitat Bozkurt L, Gobl CS, Tura A, et al. Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS ONE. 2012;7(2):e32710.PubMedCrossRefPubMedCentral Bozkurt L, Gobl CS, Tura A, et al. Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS ONE. 2012;7(2):e32710.PubMedCrossRefPubMedCentral
8.
Zurück zum Zitat Forbes S, Godsland IF, Taylor-Robinson SD, et al. A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. Diabetologia. 2013;56(9):2021–33.PubMedCrossRef Forbes S, Godsland IF, Taylor-Robinson SD, et al. A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. Diabetologia. 2013;56(9):2021–33.PubMedCrossRef
9.
Zurück zum Zitat Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA. Gestational diabetes Mellitus is strongly Associated with non-alcoholic fatty liver disease. Am J Gastroenterol. 2016;111(5):658–64.PubMedCrossRefPubMedCentral Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA. Gestational diabetes Mellitus is strongly Associated with non-alcoholic fatty liver disease. Am J Gastroenterol. 2016;111(5):658–64.PubMedCrossRefPubMedCentral
10.
Zurück zum Zitat Lavrentaki A, Thomas T, Subramanian A, et al. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: a population-based cohort study, systematic review and meta-analysis. J Diabetes Complications. 2019;33(10):107401.PubMedCrossRef Lavrentaki A, Thomas T, Subramanian A, et al. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: a population-based cohort study, systematic review and meta-analysis. J Diabetes Complications. 2019;33(10):107401.PubMedCrossRef
11.
Zurück zum Zitat Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70(5):962–9.PubMedCrossRef Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70(5):962–9.PubMedCrossRef
12.
Zurück zum Zitat Kim Y, Chang Y, Ryu S, Wild SH, Byrne CD. NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status. Hepatology. 2022;76(6):1755–65.PubMedCrossRef Kim Y, Chang Y, Ryu S, Wild SH, Byrne CD. NAFLD improves risk prediction of type 2 diabetes: with effect modification by sex and menopausal status. Hepatology. 2022;76(6):1755–65.PubMedCrossRef
13.
Zurück zum Zitat Chang Y, Ryu S, Sung KC, et al. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. Gut. 2019;68(9):1667–75.PubMedCrossRef Chang Y, Ryu S, Sung KC, et al. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. Gut. 2019;68(9):1667–75.PubMedCrossRef
14.
Zurück zum Zitat Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the american Gastroenterological Association, American Association for the study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592–609.PubMedCrossRef Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the american Gastroenterological Association, American Association for the study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592–609.PubMedCrossRef
15.
Zurück zum Zitat Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.PubMedCrossRef Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.PubMedCrossRef
16.
Zurück zum Zitat World Health Organization, Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000. World Health Organization, Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000.
17.
Zurück zum Zitat Committee ADAPP. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2021;45(Supplement1):17–S38. Committee ADAPP. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2021;45(Supplement1):17–S38.
18.
Zurück zum Zitat Weinert LS. International Association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of diabetes and pregnancy study groups Consensus Panel. Diabetes Care. 2010;33(7):e97. author reply e8.PubMedCrossRef Weinert LS. International Association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of diabetes and pregnancy study groups Consensus Panel. Diabetes Care. 2010;33(7):e97. author reply e8.PubMedCrossRef
19.
Zurück zum Zitat Beekers P, Jamaladin H, van Drongelen J, Roeleveld N, van Gelder M. Data from web-based questionnaires were valid for gestational diabetes and Preeclampsia, but not gestational hypertension. J Clin Epidemiol. 2020;125:84–90.PubMedCrossRef Beekers P, Jamaladin H, van Drongelen J, Roeleveld N, van Gelder M. Data from web-based questionnaires were valid for gestational diabetes and Preeclampsia, but not gestational hypertension. J Clin Epidemiol. 2020;125:84–90.PubMedCrossRef
20.
Zurück zum Zitat Donnelly SR, Hinkle SN, Rawal S, et al. Prospective study of gestational diabetes and fatty liver scores 9 to 16 years after pregnancy. J Diabetes. 2019;11(11):895–905.PubMedCrossRef Donnelly SR, Hinkle SN, Rawal S, et al. Prospective study of gestational diabetes and fatty liver scores 9 to 16 years after pregnancy. J Diabetes. 2019;11(11):895–905.PubMedCrossRef
21.
Zurück zum Zitat Association KD. Treatment guideline for diabetes. Korean Diabetes Association. 2019;6 ed. Association KD. Treatment guideline for diabetes. Korean Diabetes Association. 2019;6 ed.
22.
Zurück zum Zitat Cheol Seong S, Kim YY, Khang YH, et al. Data Resource Profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799–800.PubMed Cheol Seong S, Kim YY, Khang YH, et al. Data Resource Profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2017;46(3):799–800.PubMed
23.
Zurück zum Zitat Hinkle SN, Rawal S, Zhu Y, Grewal J, Albert PS, Zhang C. Validation of self-reported diagnosis of gestational diabetes at 6-weeks Postpartum. Epidemiology. 2017;28(5):747–52.PubMedCrossRefPubMedCentral Hinkle SN, Rawal S, Zhu Y, Grewal J, Albert PS, Zhang C. Validation of self-reported diagnosis of gestational diabetes at 6-weeks Postpartum. Epidemiology. 2017;28(5):747–52.PubMedCrossRefPubMedCentral
24.
Zurück zum Zitat Mathiesen UL, Franzen LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34(7):516–22.PubMedCrossRef Mathiesen UL, Franzen LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34(7):516–22.PubMedCrossRef
25.
Zurück zum Zitat VanderWeele TJ, Ding P. Sensitivity analysis in Observational Research: introducing the E-Value. Ann Intern Med. 2017;167(4):268–74.PubMedCrossRef VanderWeele TJ, Ding P. Sensitivity analysis in Observational Research: introducing the E-Value. Ann Intern Med. 2017;167(4):268–74.PubMedCrossRef
26.
Zurück zum Zitat Erfanpoor S, Etemad K, Kazempour S, et al. Diabetes, hypertension, and incidence of chronic kidney disease: is there any Multiplicative or Additive Interaction? Int J Endocrinol Metab. 2021;19(1):e101061.PubMed Erfanpoor S, Etemad K, Kazempour S, et al. Diabetes, hypertension, and incidence of chronic kidney disease: is there any Multiplicative or Additive Interaction? Int J Endocrinol Metab. 2021;19(1):e101061.PubMed
27.
Zurück zum Zitat Uno H, Cai T, Pencina MJ, D’Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30(10):1105–17.PubMedCrossRefPubMedCentral Uno H, Cai T, Pencina MJ, D’Agostino RB, Wei LJ. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011;30(10):1105–17.PubMedCrossRefPubMedCentral
28.
Zurück zum Zitat Gray LJ, Khunti K, Edwardson C, et al. Implementation of the automated Leicester Practice Risk score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance. Diabetologia. 2012;55(12):3238–44.PubMedCrossRef Gray LJ, Khunti K, Edwardson C, et al. Implementation of the automated Leicester Practice Risk score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance. Diabetologia. 2012;55(12):3238–44.PubMedCrossRef
29.
Zurück zum Zitat Woo YC, Lee CH, Fong CHY, Tso AWK, Cheung BMY, Lam KSL. Validation of the diabetes screening tools proposed by the american Diabetes Association in an aging chinese population. PLoS ONE. 2017;12(9):e0184840.PubMedCrossRefPubMedCentral Woo YC, Lee CH, Fong CHY, Tso AWK, Cheung BMY, Lam KSL. Validation of the diabetes screening tools proposed by the american Diabetes Association in an aging chinese population. PLoS ONE. 2017;12(9):e0184840.PubMedCrossRefPubMedCentral
31.
Zurück zum Zitat Fraser G, Yan R. Guided multiple imputation of missing data: using a subsample to strengthen the missing-at-random assumption. Epidemiology. 2007;18(2):246–52.PubMedCrossRef Fraser G, Yan R. Guided multiple imputation of missing data: using a subsample to strengthen the missing-at-random assumption. Epidemiology. 2007;18(2):246–52.PubMedCrossRef
32.
Zurück zum Zitat Gray LJ, Taub NA, Khunti K, et al. The Leicester Risk Assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med. 2010;27(8):887–95.PubMedCrossRef Gray LJ, Taub NA, Khunti K, et al. The Leicester Risk Assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med. 2010;27(8):887–95.PubMedCrossRef
33.
Zurück zum Zitat Bang H, Edwards AM, Bomback AS, et al. Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 2009;151(11):775–83.PubMedCrossRefPubMedCentral Bang H, Edwards AM, Bomback AS, et al. Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 2009;151(11):775–83.PubMedCrossRefPubMedCentral
34.
Zurück zum Zitat Kubihal S, Gupta Y, Shalimar, et al. Prevalence of non-alcoholic fatty liver disease and factors associated with it in indian women with a history of gestational diabetes mellitus. J Diabetes Investig. 2021;12(5):877–85.PubMedCrossRef Kubihal S, Gupta Y, Shalimar, et al. Prevalence of non-alcoholic fatty liver disease and factors associated with it in indian women with a history of gestational diabetes mellitus. J Diabetes Investig. 2021;12(5):877–85.PubMedCrossRef
35.
Zurück zum Zitat Mehmood S, Margolis M, Ye C, et al. Hepatic fat and glucose tolerance in women with recent gestational diabetes. BMJ Open Diabetes Res Care. 2018;6(1):e000549.PubMedCrossRefPubMedCentral Mehmood S, Margolis M, Ye C, et al. Hepatic fat and glucose tolerance in women with recent gestational diabetes. BMJ Open Diabetes Res Care. 2018;6(1):e000549.PubMedCrossRefPubMedCentral
36.
Zurück zum Zitat Kendler KS, Gardner CO. Interpretation of interactions: guide for the perplexed. Br J Psychiatry. 2010;197(3):170–1.PubMedCrossRef Kendler KS, Gardner CO. Interpretation of interactions: guide for the perplexed. Br J Psychiatry. 2010;197(3):170–1.PubMedCrossRef
37.
Zurück zum Zitat Hagstrom H, Hoijer J, Ludvigsson JF, et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int. 2016;36(2):268–74.PubMedCrossRef Hagstrom H, Hoijer J, Ludvigsson JF, et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int. 2016;36(2):268–74.PubMedCrossRef
38.
Zurück zum Zitat Lee SM, Kwak SH, Koo JN, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia. 2019;62(2):238–48.PubMedCrossRef Lee SM, Kwak SH, Koo JN, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia. 2019;62(2):238–48.PubMedCrossRef
39.
Zurück zum Zitat Lee SM, Hwangbo S, Norwitz ER, et al. Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods. Clin Mol Hepatol. 2022;28(1):105–16.PubMedCrossRef Lee SM, Hwangbo S, Norwitz ER, et al. Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods. Clin Mol Hepatol. 2022;28(1):105–16.PubMedCrossRef
40.
Zurück zum Zitat Lappas M, Mundra PA, Wong G, et al. The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics. Diabetologia. 2015;58(7):1436–42.PubMedCrossRef Lappas M, Mundra PA, Wong G, et al. The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics. Diabetologia. 2015;58(7):1436–42.PubMedCrossRef
41.
Zurück zum Zitat Kengne AP, Beulens JW, Peelen LM, et al. Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol. 2014;2(1):19–29.PubMedCrossRef Kengne AP, Beulens JW, Peelen LM, et al. Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol. 2014;2(1):19–29.PubMedCrossRef
42.
Zurück zum Zitat Ha KH, Lee KA, Han KD, Moon MK, Kim DJ. Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes. Korean J Intern Med. 2023;38(1):93–100.PubMedCrossRef Ha KH, Lee KA, Han KD, Moon MK, Kim DJ. Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes. Korean J Intern Med. 2023;38(1):93–100.PubMedCrossRef
43.
Zurück zum Zitat Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.PubMedCrossRef
44.
Zurück zum Zitat Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce Cardiovascular Morbidity and Mortality: A Simulation of the results of the anglo-danish-dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449–55.PubMedCrossRefPubMedCentral Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce Cardiovascular Morbidity and Mortality: A Simulation of the results of the anglo-danish-dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449–55.PubMedCrossRefPubMedCentral
45.
Zurück zum Zitat Diaz-Santana MV, O’Brien KM, Park YM, Sandler DP, Weinberg CR. Persistence of risk for type 2 diabetes after gestational diabetes Mellitus. Diabetes Care. 2022;45(4):864–70.PubMedCrossRefPubMedCentral Diaz-Santana MV, O’Brien KM, Park YM, Sandler DP, Weinberg CR. Persistence of risk for type 2 diabetes after gestational diabetes Mellitus. Diabetes Care. 2022;45(4):864–70.PubMedCrossRefPubMedCentral
46.
Zurück zum Zitat Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612.PubMedCrossRef Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612.PubMedCrossRef
47.
Zurück zum Zitat Xiang AH, Kjos SL, Takayanagi M, Trigo E, Buchanan TA. Detailed physiological characterization of the development of type 2 diabetes in hispanic women with prior gestational diabetes mellitus. Diabetes. 2010;59(10):2625–30.PubMedCrossRefPubMedCentral Xiang AH, Kjos SL, Takayanagi M, Trigo E, Buchanan TA. Detailed physiological characterization of the development of type 2 diabetes in hispanic women with prior gestational diabetes mellitus. Diabetes. 2010;59(10):2625–30.PubMedCrossRefPubMedCentral
48.
Zurück zum Zitat Xiang AH, Kawakubo M, Trigo E, Kjos SL, Buchanan TA. Declining beta-cell compensation for insulin resistance in hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care. 2010;33(2):396–401.PubMedCrossRef Xiang AH, Kawakubo M, Trigo E, Kjos SL, Buchanan TA. Declining beta-cell compensation for insulin resistance in hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein. Diabetes Care. 2010;33(2):396–401.PubMedCrossRef
49.
Zurück zum Zitat Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32–42.PubMedCrossRef Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32–42.PubMedCrossRef
50.
Zurück zum Zitat McAuley KA, Mann JI, Chase JG, Lotz TF, Shaw GM. Point: HOMA–satisfactory for the time being: HOMA: the best bet for the simple determination of insulin sensitivity, until something better comes along. Diabetes Care. 2007;30(9):2411–3.PubMedCrossRef McAuley KA, Mann JI, Chase JG, Lotz TF, Shaw GM. Point: HOMA–satisfactory for the time being: HOMA: the best bet for the simple determination of insulin sensitivity, until something better comes along. Diabetes Care. 2007;30(9):2411–3.PubMedCrossRef
51.
Zurück zum Zitat Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011;34(Suppl 2):184–90.CrossRef Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011;34(Suppl 2):184–90.CrossRef
Metadaten
Titel
Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes
verfasst von
Yoosun Cho
Yoosoo Chang
Seungho Ryu
Sarah H. Wild
Christopher D. Byrne
Publikationsdatum
31.05.2023
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 8/2023
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-023-01016-1

Weitere Artikel der Ausgabe 8/2023

European Journal of Epidemiology 8/2023 Zur Ausgabe